Difference between revisions of "Research/nci-role/spotlight/profiles"
Jump to navigation
Jump to search
(Created page with "== Profiles in Cancer Research == The men and women who contribute to cancer research come from a variety of disciplines and backgrounds. These profiles highlight the work of...") |
|||
| Line 3: | Line 3: | ||
The men and women who contribute to cancer research come from a variety of disciplines and backgrounds. These profiles highlight the work of NCI and NCI-funded researchers, clinicians, and others and describe what led them to embark on a career in cancer research. | The men and women who contribute to cancer research come from a variety of disciplines and backgrounds. These profiles highlight the work of NCI and NCI-funded researchers, clinicians, and others and describe what led them to embark on a career in cancer research. | ||
| − | Sharon Savage, M.D | + | {| |
| − | + | |- | |
| + | | | ||
| + | [[File:Sharon-savage-thumb.jpg|200px|left]] | ||
| + | || | ||
| + | :Sharon Savage, M.D. | ||
| − | + | :The chief of the Clinical Genetics Branch in NCI’s Division of Cancer Epidemiology and Genetics studies the association between telomere length and cancer risk. | |
| − | The chief of the | + | |} |
| − | |||
| − | |||
| − | + | {| | |
| − | + | |- | |
| + | | | ||
| + | [[File:W-marston-linehan-thumb.jpg|left]] | ||
| + | || | ||
| + | :W. Marston Linehan, M.D. | ||
| − | + | :The chief of the Urologic Oncology Branch in NCI’s Center for Cancer Research investigates gene pathways in kidney cancer to find new treatment strategies. | |
| − | The | + | |} |
| − | |||
| − | |||
| + | {| | ||
| + | |- | ||
| + | | | ||
| + | [[File:James-gulley-thumb.jpg|left]] | ||
| + | || | ||
| + | :James Gulley, M.D., Ph.D. | ||
| − | David Q. Matus, Ph.D. | + | :The head of the Clinical Trials Group in NCI’s Laboratory of Tumor Immunology and Biology explores how to harness the power of the body’s immune system to fight cancer more effectively. |
| − | David Matus studies cellular invasion during normal development in the worm, C. elegans, as a model for understanding this behavior in metastatic cancer cells. | + | |} |
| + | |||
| + | :Mark Schiffman, M.D., M.P.H. | ||
| + | |||
| + | :The senior investigator in the Clinical Genetics Branch of NCI’s Division of Cancer Epidemiology and Genetics uses molecular epidemiology to predict and prevent cervical cancer. | ||
| + | |||
| + | :Christina Annunziata, M.D., Ph.D. | ||
| + | |||
| + | :The investigator in NCI’s Center for Cancer Research studies the role of NF-κB signaling in ovarian cancer. | ||
| + | |||
| + | :Christal Sohl, Ph.D. | ||
| + | |||
| + | :The San Diego State University biologist uses a variety of methods, including structural, computational, and kinetic analyses, to study enzymes that may play a role in cancer. | ||
| + | |||
| + | |||
| + | :David Q. Matus, Ph.D. | ||
| + | |||
| + | :David Matus studies cellular invasion during normal development in the worm, C. elegans, as a model for understanding this behavior in metastatic cancer cells. | ||
Revision as of 22:25, 11 September 2019
Profiles in Cancer Research
The men and women who contribute to cancer research come from a variety of disciplines and backgrounds. These profiles highlight the work of NCI and NCI-funded researchers, clinicians, and others and describe what led them to embark on a career in cancer research.
 |
|
 |
|
 |
|
- Mark Schiffman, M.D., M.P.H.
- The senior investigator in the Clinical Genetics Branch of NCI’s Division of Cancer Epidemiology and Genetics uses molecular epidemiology to predict and prevent cervical cancer.
- Christina Annunziata, M.D., Ph.D.
- The investigator in NCI’s Center for Cancer Research studies the role of NF-κB signaling in ovarian cancer.
- Christal Sohl, Ph.D.
- The San Diego State University biologist uses a variety of methods, including structural, computational, and kinetic analyses, to study enzymes that may play a role in cancer.
- David Q. Matus, Ph.D.
- David Matus studies cellular invasion during normal development in the worm, C. elegans, as a model for understanding this behavior in metastatic cancer cells.
